EXAGEN INC. (XGN) News
Filter XGN News Items
XGN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
XGN News Highlights
- For XGN, its 30 day story count is now at 6.
- Over the past 16 days, the trend for XGN's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about XGN are LI, UL and PR.
Latest XGN News From Around the Web
Below are the latest news stories about EXAGEN INC that investors may wish to consider to help them evaluate XGN as an investment opportunity.
Exagen (NASDAQ:XGN) shareholders are up 20% this past week, but still in the red over the last three yearsExagen Inc. ( NASDAQ:XGN ) shareholders will doubtless be very grateful to see the share price up 43% in the last... |
Q1 2023 Exagen Inc Earnings CallQ1 2023 Exagen Inc Earnings Call |
Exagen GAAP EPS of -$0.44 beats by $0.12, revenue of $11.2M beats by $1.8M
|
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue EstimatesExagen Inc. (XGN) delivered earnings and revenue surprises of 15.38% and 18.21%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
Exagen Inc. Reports First Quarter 2023 ResultsRecord Physician Demand for AVISE® CTDSAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN)("Exagen"), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2023. First Quarter Highlights: Delivered a record 37,312 AVISE® CTD tests in the first quarter, a 21% increase over the first quarter of 2022 and a 10% increase over the fourth quarter of 2022.Recognized total revenue of $11.2 million for the first quarter, an 8% |
Exagen Announces Campaign for Lupus Awareness MonthSAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign focusing on providers, patients and partnership activities that enhance the impactful work being done to help those suffering from Systemic Lupus Erythematosus (SLE). Lupus Awareness Month occurs every May and is an opportunity for lupus-focused organizations to take intentional steps in creat |
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023SAN DIEGO, April 24, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2023, after the market close on Monday, May 15, 2023. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 4:30 PM ET (1:30 PM PT). Interested parties may access the conference call by dialing (201) |
Exagen Inc. (NASDAQ:XGN) Q4 2022 Earnings Call TranscriptExagen Inc. (NASDAQ:XGN) Q4 2022 Earnings Call Transcript March 20, 2023 Operator: Greetings, and welcome to the Exagen Inc. Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure […] |
Exagen Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsExagen ( NASDAQ:XGN ) Full Year 2022 Results Key Financial Results Revenue: US$45.6m (down 5.7% from FY 2021). Net... |
Q4 2022 Exagen Inc Earnings CallQ4 2022 Exagen Inc Earnings Call |